GeneNews Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.03 |
Market Cap |
$26.42 M |
Shares Outstanding |
143.29 M |
Public Float |
- |
GeneNews Ltd. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.05 |
Market Cap |
CAD8.62 M |
Shares Outstanding |
143.59 M |
Public Float |
124.27 M |
Address |
70 East Beaver Creek Road Richmond Hill Ontario L4B 3B2 Canada |
Employees | - |
Website | http://www.stagezerolifesciences.com |
Updated | 07/08/2019 |
GeneNews Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for early detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. |